Nuix Ltd (ASX:NXL) Expands Agentic AI as Neo Reaches 30% of Contract Value

Aditi Sarkar

26 October 2026 06:43 PM AEDT

Nuix Ltd (ASX:NXL) Expands Agentic AI as Neo Reaches 30% of Contract Value

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Nuix Ltd (ASX:NXL) reported FY26 annualised contract value of $260.0 million, up 13.9%, and revenue of $263.2 million, up 18.8%.
Nuix Neo ACV rose 179% to $78.5 million across 135 customers, representing 30% of total ACV.
Statutory NPAT was a $16.4 million profit, compared with a $9.2 million loss in FY25.
FY27 guidance targets ACV of $285 million to $300 million, including a one-off $15 million R&D investment.

Nuix is a provider of investigative analytics and intelligence software used by organisations to process and examine large volumes of unstructured data.

Company Business

Nuix's software is used in legal, regulatory, criminal investigation and compliance work, where users need to search and analyse emails, chats, documents, images and other material at scale. Its flagship Nuix Neo platform combines data processing, analytics and artificial intelligence features, while Nuix Discover supports legal review. In April 2026, Nuix acquired Linkurious, adding graph analytics capabilities that help users trace connections between people, accounts and transactions. The company sells primarily through multi-year and annual licences, measured through annualised contract value (ACV). During FY26, the company restructured its go-to-market function with new regional sales teams and a Chief Customer Officer, and unified its product and technology teams under the Chief Technology Officer.

Recent Development

Nuix has made several AI-focused product announcements in recent weeks. In early October 2026, the company introduced a Generative AI Framework designed to add governance and auditability to large language models used in high-stakes legal and investigative work. In late October 2026, Nuix launched the Nuix Neo AI Agent, which answers plain-language questions, links each answer to its source material and logs every step taken, so users can explain their findings to courts, boards and regulators.

According to the company, the agent draws on more than 20 tools within Nuix Neo, can work across entire case inventories under role-based access controls, and integrates with the Nuix knowledge graph to generate graph queries automatically. Administrators can cap spending, track usage and set guardrails on prompts and responses. The agent runs on the Neo Gen AI Framework, which connects a customer's chosen supported large language model to Nuix's data processing layer. CEO John Ruthven said the agent is built to show its reasoning, with answers traceable to sources and reviewable steps. Nuix also showcased Nuix Neo at the Sibos event in Miami, focusing on financial crime detection within unstructured data.

Financial Performance and Sector Context

For the year ended June 30, 2026, Nuix Ltd (ASX:NXL) reported ACV of $260.0 million, up 13.9% from $228.4 million. Excluding Linkurious, organic ACV grew 8.6%, or 11.1% in constant currency. Revenue rose 18.8% to $263.2 million. Adjusted Management EBITDA increased 60.4% to $59.8 million, lifting the margin to 22.7% from 16.8%, while statutory EBITDA rose 40.5% to $66.9 million. Statutory NPAT was a profit of $16.4 million, reversing a loss of $9.2 million in the prior year.

Cash generation improved markedly. Underlying cash flow rose 154% to $51.0 million, free cash flow reached $37.4 million compared with $4.0 million, and net cash increased 24.8% to $49.9 million. Net dollar retention reached 105.2% at year end, up from 101.0% at the half, and churn was 6.6%. Multi-year deals accounted for 35% of revenue, compared with 27% previously.

Nuix Neo remains the main growth driver, with Neo ACV up 179% to $78.5 million across 135 customers. Neo now represents 30% of total ACV, more than double its share twelve months earlier. Linkurious contributed an ACV run rate of $12.0 million and revenue of $3.8 million in the 72 days after acquisition.

Risks to Consider

Nuix has guided to Adjusted Management EBITDA similar to FY26 in FY27, as it absorbs a one-off $15 million R&D Accelerator investment. Growth is expected to be weighted to the second half, which places emphasis on contract timing and renewals late in the year. The company restructured its go-to-market teams, and one-off restructuring costs have not been quantified. Guidance assumes an AUD/USD rate of 0.70, so currency movements can affect reported outcomes. The Federal Court dismissed all ASIC claims against the company and the then individual directors, but ASIC has appealed the dismissal relating to the company, and that appeal remains pending.

What to Watch Next

For FY27, Nuix expects ACV of $285 million to $300 million, with continued growth in Nuix Neo. Investors following ASX:NXL may watch adoption of the Neo AI Agent and Generative AI Framework, cross-selling of Linkurious into the existing customer base, the progress of the R&D Accelerator program, net dollar retention and churn trends, and the outcome of the ASIC appeal. The upcoming annual general meeting may also provide a trading update.

Key Insights

Nuix Ltd (ASX:NXL) returned to statutory profit in FY26 and lifted ACV, revenue and cash flow, with Nuix Neo now forming close to a third of contract value. Its latest AI releases centre on traceable, auditable answers for regulated and legal settings. FY27 guidance points to higher ACV with flat earnings as the company funds additional product investment. For ASX:NXL, the balance between AI product spending and earnings delivery is likely to remain a key point of focus.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.